| (210) | Number of the EPO application | 21724651 |
| (220) | Filing date of the EPO application | 2021.05.07 |
| (80) | EPO patent specification publication (B) | EPB nr. 01/2024, 2024.01.03 |
| (110) | EPO patent number | 4025187 |
| (21) | Number of the application | e 2022 0794 |
| (71) | Name(s) of applicant(s), code of the country | JANSSEN PHARMACEUTICA NV, BE; |
| (72) | Name(s) of inventor(s), code of the country | GOPAL Srihari, US;
VENKATASUBRAMANIAN Raja, US;
T'JOLLYN Huybrecht, BE; |
| (73) | Name(s) of owner(s), code of the country | JANSSEN PHARMACEUTICA NV, BE; |
| (54) | Title of the invention | DOSING REGIMENS ASSOCIATED WITH EXTENDED RELEASE PALIPERIDONE INJECTABLE FORMULATIONS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 9/00 (2006.01.01); A61K 9/10 (2006.01.01); A61K 31/519 (2006.01.01); A61P 25/18 (2006.01.01); A61P 25/24 (2006.01.01) |
| (19) | Country | BE |
| (41) | Date of publication of the application | 2022.08.31 |
| (30) | Priority | 202063119382 P, 2020.11.30, US |
| (86) | International application | PCT/EP2021/062144, 2021.05.07 |
| (87) | International publication | WO 2022/111858, 2022.06.02 |